These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17940420)

  • 1. The role of peptide YY in integrative gut physiology and potential role in obesity.
    Grudell AB; Camilleri M
    Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):52-7. PubMed ID: 17940420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?
    Hanusch-Enserer U; Roden M
    Eur J Clin Invest; 2005 Jul; 35(7):425-30. PubMed ID: 16008543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
    N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.
    Vazquez Roque MI; Camilleri M; Stephens DA; Jensen MD; Burton DD; Baxter KL; Zinsmeister AR
    Gastroenterology; 2006 Dec; 131(6):1717-24. PubMed ID: 17087952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYY transgenic mice are protected against diet-induced and genetic obesity.
    Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY levels are elevated after gastric bypass surgery.
    Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
    Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meal-related changes in ghrelin, peptide YY, and appetite in normal weight and overweight children.
    Lomenick JP; Clasey JL; Anderson JW
    Obesity (Silver Spring); 2008 Mar; 16(3):547-52. PubMed ID: 18239577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women.
    Sodowski K; Zwirska-Korczala K; Kuka D; Kukla M; Budziszewska P; Czuba B; Włoch A; Cnota W; Bielański W; Brzozowski T; Rehfeld JF; Zdun R; Konturek PC
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():37-52. PubMed ID: 17443026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut hormones and the control of appetite.
    Small CJ; Bloom SR
    Trends Endocrinol Metab; 2004 Aug; 15(6):259-63. PubMed ID: 15358278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypothalamus, hormones, and hunger: alterations in human obesity and illness.
    Goldstone AP
    Prog Brain Res; 2006; 153():57-73. PubMed ID: 16876568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.
    Wynne K; Bloom SR
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):612-20. PubMed ID: 17082808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
    Ballantyne GH
    Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits.
    Sileno AP; Brandt GC; Spann BM; Quay SC
    Int J Obes (Lond); 2006 Jan; 30(1):68-72. PubMed ID: 16172618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide YY levels are associated with appetite suppression in response to long-chain fatty acids.
    Stoeckel LE; Weller RE; Giddings M; Cox JE
    Physiol Behav; 2008 Jan; 93(1-2):289-95. PubMed ID: 17936861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial changes in gut regulatory peptides in gastric bypass patients.
    Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
    Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of peptide YY levels by age, hormonal, and nutritional status.
    Tovar SA; Seoane LM; Caminos JE; Nogueiras R; Casanueva FF; Diéguez C
    Obes Res; 2004 Dec; 12(12):1944-50. PubMed ID: 15687395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.
    Valderas JP; Irribarra V; Boza C; de la Cruz R; Liberona Y; Acosta AM; Yolito M; Maiz A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1069-75. PubMed ID: 20097707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bariatric surgery on gut hormones that alter appetite.
    Pournaras DJ; Le Roux CW
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):508-12. PubMed ID: 20152735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.